XML 21 R6.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements Of Cash Flows - USD ($)
$ in Millions
 9 Months Ended
Nov. 02, 2024
Oct. 28, 2023
Operating activities    
Net income (loss) $ (39.4) $ 184.2
Adjustments to reconcile net (loss) income to net cash used in operating activities:    
Depreciation and amortization 110.6 129.4
Amortization of unfavorable contracts (1.4) (1.4)
Share-based compensation 20.4 36.4
Deferred taxation (6.5) 40.2
Asset impairments, net 169.3 5.7
Other non-cash movements 4.3 4.3
Changes in operating assets and liabilities:    
Inventories (189.5) 14.8
Other assets 38.0 (41.7)
Accounts payable (101.5) (221.5)
Accrued expenses and other liabilities (45.9) (253.2)
Change in operating lease assets and liabilities (14.0) (34.5)
Deferred revenue (41.8) (48.0)
Income tax receivable and payable (92.4) (20.0)
Net cash used in operating activities (189.8) (205.3)
Investing activities    
Purchase of property, plant and equipment (114.4) (89.4)
Other investing activities, net (6.6) (4.5)
Net cash used in investing activities (121.0) (93.9)
Financing activities    
Dividends paid on common shares (36.0) (29.7)
Dividends paid on redeemable convertible preferred shares (18.5) (24.6)
Repurchase of common shares (113.8) (117.5)
Repurchase of redeemable convertible preferred shares 812.9 0.0
Repayment of Senior Notes (147.8) 0.0
Proceeds from ABL 253.0 0.0
Payment of debt issuance costs (4.3) 0.0
Other financing activities, net (28.2) (47.9)
Net cash used in financing activities (908.5) (219.7)
Cash and cash equivalents at beginning of period 1,378.7 1,166.8
Decrease in cash and cash equivalents (1,219.3) (518.9)
Effect of exchange rate changes on cash and cash equivalents (1.7) (4.1)
Cash and cash equivalents at end of period $ 157.7 $ 643.8